Pharmaids Pharmaceuticals Ltd

AI
Pharmaids Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Pharmaids Pharmaceuticals Ltd

₹ 32.2 0.19%
21 Aug - close price
pharmaids.com BSE: 524572
About

Incorporated in 1989, Pharmaids Pharmaceuticals Ltd operates in research, development, and manufacturing services.
It is undergoing a business transition and aims to build a CRDMO platform.[1]

Key Points

Business Overview:[1]
PPL is a fully integrated provider of Custom Research and Manufacturing Services (CRAMS) to various pharma and related companies.

Website BSE
  • Market Cap ₹ 114 Cr.
  • Current Price ₹ 32.2
  • High / Low ₹ 66.0 / 25.6
  • Stock P/E
  • Book Value ₹ 13.5
  • Dividend Yield 0.00 %
  • ROCE -18.5 %
  • ROE -26.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Debtor days have improved from 56.1 to 44.9 days.

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 33.0%
  • Company has a low return on equity of -19.4% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
0.00 0.00 0.02 5.81 4.73 5.24 4.71 4.77 6.66 8.61 5.43 7.18 4.12
1.61 1.02 2.45 11.39 8.14 7.65 7.60 8.67 12.03 13.93 7.94 7.52 4.87
Operating Profit -1.61 -1.02 -2.43 -5.58 -3.41 -2.41 -2.89 -3.90 -5.37 -5.32 -2.51 -0.34 -0.75
OPM % -12,150.00% -96.04% -72.09% -45.99% -61.36% -81.76% -80.63% -61.79% -46.22% -4.74% -18.20%
0.41 -0.26 0.76 0.12 -0.07 0.08 0.00 0.13 0.04 3.03 -0.32 0.01 4.25
Interest 0.00 0.00 0.02 0.77 0.26 0.33 0.48 1.01 1.20 0.93 0.72 0.65 0.60
Depreciation 0.01 0.01 0.04 0.63 0.57 0.61 0.64 0.62 0.61 0.47 0.48 0.48 0.49
Profit before tax -1.21 -1.29 -1.73 -6.86 -4.31 -3.27 -4.01 -5.40 -7.14 -3.69 -4.03 -1.46 2.41
Tax % 7.44% -60.47% -33.53% -7.73% -27.38% -30.58% -24.94% -11.11% -26.05% -30.62% -34.24% -25.34% 22.41%
-1.30 -0.50 -1.15 -6.33 -3.12 -2.27 -3.01 -4.80 -5.27 -2.57 -2.65 -1.09 1.88
EPS in Rs -0.61 -0.23 -0.54 -1.57 -0.76 -0.55 -0.55 -1.12 -1.39 -0.71 -0.70 -0.51 0.63
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
3.94 0.00 15.11 19.45 27.88 25.34
3.81 9.89 27.46 32.20 41.39 34.26
Operating Profit 0.13 -9.89 -12.35 -12.75 -13.51 -8.92
OPM % 3.30% -81.73% -65.55% -48.46% -35.20%
0.02 0.00 0.03 0.01 2.75 6.97
Interest 0.00 0.00 1.58 2.10 3.52 2.90
Depreciation 0.01 0.02 1.72 2.44 2.03 1.92
Profit before tax 0.14 -9.91 -15.62 -17.28 -16.31 -6.77
Tax % 0.00% -23.71% -24.20% -21.88% -29.00%
0.15 -7.56 -11.85 -13.51 -11.57 -4.43
EPS in Rs 0.15 -3.52 -2.26 -3.06 -3.32 -1.29
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 19%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -50%
TTM: 17%
Stock Price CAGR
10 Years: 27%
5 Years: 20%
3 Years: -8%
1 Year: -48%
Return on Equity
10 Years: %
5 Years: -21%
3 Years: -19%
Last Year: -27%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 10.27 21.44 35.27 35.27 35.27
Reserves -1.60 1.02 36.78 24.05 12.39
0.00 0.00 8.53 38.98 23.39
2.44 2.13 10.75 21.54 16.21
Total Liabilities 11.11 24.59 91.33 119.84 87.26
0.03 0.11 63.42 76.61 53.94
CWIP 0.45 2.00 7.00 4.53 6.10
Investments 0.00 3.31 0.00 0.00 0.00
10.63 19.17 20.91 38.70 27.22
Total Assets 11.11 24.59 91.33 119.84 87.26

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-0.26 -4.02 -10.62 -15.11 -4.06
0.47 -4.94 -74.99 -12.22 23.34
0.00 21.31 77.66 23.36 -19.97
Net Cash Flow 0.21 12.35 -7.95 -3.98 -0.69
Free Cash Flow -0.26 -5.69 -33.33 -27.37 11.05
CFO/OP -200% 41% 86% 118% 30%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 124.14 64.74 58.74 44.90
Inventory Days 90.99 0.00 111.61 346.51 8.73
Days Payable 236.18 159.18 464.29 59.17
Cash Conversion Cycle -21.05 17.17 -59.04 -5.54
Working Capital Days -17.60 -68.60 -160.26 -172.16
ROCE % -63.67% -25.99% -17.43% -18.48%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of Subsidiaries
count ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Number of Permanent Employees
count ・Standalone data
Consolidated Revenue Mix - Job Work
% of consolidated revenue
Consolidated Revenue Mix - Sale of Products
% of consolidated revenue
Consolidated Revenue Mix - Sale of Services
% of consolidated revenue
Subsidiary Revenue Share of Group Revenue
% of consolidated revenue

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
9.70% 9.25% 5.64% 5.56% 5.19% 5.22% 5.22% 5.14% 32.99% 32.99% 32.99% 32.99%
90.31% 90.75% 94.36% 94.44% 94.81% 94.79% 94.78% 94.87% 67.00% 67.01% 67.00% 67.02%
No. of Shareholders 7,3937,2817,5677,5948,0498,3498,2208,0268,0278,2888,4068,632

Documents

Announcements

Annual reports